Tourette syndrome associated with mental retardation: a single-subject treatment study with haloperidol

Am J Ment Retard. 1997 Mar;101(5):497-504.

Abstract

A Tic Checklist and direct observation tic measurement procedure were developed for the assessment of Tourette syndrome in individuals with mental retardation. Using a single-subject reversal design, we applied this assessment method to the evaluation of haloperidol treatment for a subject with Tourette syndrome and severe mental retardation. Relative to baseline, haloperidol 10 mg/day produced decreases of 66% in simple motor tics, 46% in complex motor tics, 45% in simple vocal tics, and 50% in complex vocal tics. Improvement was also seen in careprovider ratings of tic severity, hyperactivity, and compulsive behaviors.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Anti-Dyskinesia Agents / therapeutic use*
  • Female
  • Haloperidol / therapeutic use*
  • Humans
  • Intellectual Disability / complications*
  • Longitudinal Studies
  • Psychiatric Status Rating Scales*
  • Time Factors
  • Tourette Syndrome / complications
  • Tourette Syndrome / drug therapy*

Substances

  • Anti-Dyskinesia Agents
  • Haloperidol